Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe
Go back to Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe| Edwards Lifesciences (NYSE: EW) | Delayed: 89.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.07 | 52 Week High | $166.87 | |||
| Open | $89.07 | 52 Week Low | $72.20 | |||
| Day High | $89.07 | P/E | 25.89 | |||
| Day Low | $89.07 | EPS | $3.44 | |||
| Volume | 307 | |||||



